EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 34, No. 3, 184-193, July 2002 Genome-wide expression profiling of 8-chloroadenosine- and 8-chloro-cAMP-treated human neuroblastoma cells using radioactive human cDNA microarray Gil Hong Park1, Jaegol Choe2, involved in proliferation and transformation (trans- Hyo-Jung Choo1, Yun Gyu Park1, forming growth factor-β, DYRK2, urokinase-type Jeongwon Sohn1, and Meyoung-kon Kim1,3 plasminogen activator and proteins involved in tran- scription and translation) which were in close paral- lel with those by 8-Cl-cAMP. Our results indicated 1Department of Biochemistry, College of Medicine, Korea University, that the two drugs shared common genomic path- Seoul, 136-701, Korea ways for the down-regulation of certain genes, but 2Department of Nuclear Medicine, College of Medicine, Korea Uni- used distinct pathways for the up-regulation of dif- versity, Seoul, 136-701, Korea ferent gene clusters. Based on the findings, we sug- 3Corresponding author: Tel, +82-2-920-6184; gest that the anti-cancer activity of 8-Cl-cAMP Fax, +82-2-923-0480; E-mail,
[email protected] results at least in part through 8-Cl-adenosine. Thus, the systematic use of DNA arrays can provide Received 30 May , 2002 insight into the dynamic cellular pathways involved in anticancer activities of chemotherapeutics. Abbreviations: 8-Cl-adenosine, 8-chloro-adenosine; 8-Cl-cAMP, 8- chloro-cyclic adenosine 3,5-monophosphate; PKA, protein kinase Keywords: 8-Cl-adenosine, 8-Cl-cAMP, anticancer activ- A; RFXAP, regulatory factor X-associated protein;